Comments on:

Democratic bid to allow suits against generic drugs called 'trial lawyer bonanza'

Back to the article » By |
A demand by House and Senate Democrats that the Food and Drug Administration clear the way to let consumers sue generic drug makers is coming under fire, with critics dubbing the effort a payoff to trial lawyers. At issue is a new Supreme Court ruling barring suits against generic drug firms accused of providing insufficient label warnings. The 5-4 decision restricts suits for so-called...